Myotact

Myotact is an innovative startup addressing a significant medical challenge: phantom limb pain experienced by amputees. With over 65 million amputees worldwide, and only 7% of treated patients finding effective relief, Myotact has developed a groundbreaking solution. The company offers a medical device designed for home use that combines muscle activity monitoring (EMG) with vibro-tactile feedback, translating this activity into virtual movements. This device, known as the Myotact bracelet, is equipped with 8 electromyographic muscle sensors and 8 vibrators, providing biofeedback through vibration. This is coupled with an application that facilitates sensory and visual rehabilitation.

Myotact primarily serves amputees who suffer from phantom limb pain and those who have difficulty mastering myoelectric prostheses. The company operates in the medical device market, specifically focusing on rehabilitation and pain management solutions.

The business model of Myotact revolves around the sale of its proprietary medical device and the accompanying application. Revenue is generated through direct sales to consumers, partnerships with healthcare providers, and potentially through licensing agreements with other medical technology companies.

Myotact's technology is the result of three years of research by the Hybrid team within the Institute of Cognitive and Integrative Neurosciences of Aquitaine (INCIA), in collaboration with the CNRS and the University of Bordeaux. The company is also supported by Unitec, a major startup incubator in the Bordeaux region, which has facilitated the creation of numerous startups.

In summary, Myotact is a pioneering company in the medical device industry, offering a unique solution to a widespread problem, with a strong foundation in research and strategic partnerships.

Keywords: Phantom Limb Pain, Amputees, Medical Device, EMG, Vibro-Tactile Feedback, Rehabilitation, Biofeedback, Myoelectric Prosthesis, Healthcare, Startup.